Structure, function, aging and turnover of aggrecan in the intervertebral disc

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 10, 2014, Pages 3181-3189

  Sivan, Sarit Sara ^a   Wachtel, Ellen ^b   Roughley, Peter ^c  

^a ORT BRAUDE COLLEGE   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Aggrecan; Biomimetics; Degeneration; Intervertebral disc; Repair; Turnover

Indexed keywords

AGGRECAN; ASPARTIC ACID; CORE PROTEIN; GLYCOSAMINOGLYCAN; HYALURONIC ACID;

AGING; AMINO TERMINAL SEQUENCE; BIOMIMETICS; CARBOHYDRATE SYNTHESIS; DISEASE ASSOCIATION; G1 REGION; G2 REGION; G3 REGION; GLYCATION; HUMAN; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DISEASE; METABOLIC RATE; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN MODIFICATION; RACEMIZATION; REVIEW;

AGGRECAN; BIOMIMETICS; DEGENERATION; INTERVERTEBRAL DISC; REPAIR; TURNOVER;

AGGRECANS; AGING; ANIMALS; HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84907863197     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.07.013     Document Type: Review

References (103)

1. H. Watanabe, Y. Yamada, and K. Kimata Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function J. Biochem. 124 1998 687 693
2. K. Doege, M. Sasaki, E. Horigan, J.R. Hassell, and Y. Yamada Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones J. Biol. Chem. 262 1987 17757 17767
3. K.J. Doege, M. Sasaki, T. Kimura, and Y. Yamada Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms J. Biol. Chem. 266 1991 894 902
4. T.M. Hering, J. Kollar, and T.D. Huynh Complete coding sequence of bovine aggrecan: comparative structural analysis Arch. Biochem. Biophys. 345 1997 259 270
5. E. Walcz, F. Deak, P. Erhardt, S.N. Coulter, C. Fulop, P. Horvath, K.J. Doege, and T.T. Glant Complete coding sequence, deduced primary structure, chromosomal localization, and structural analysis of murine aggrecan Genomics 22 1994 364 371
6. H. Li, N.B. Schwartz, and B.M. Vertel cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia J. Biol. Chem. 268 1993 23504 23511
7. M.T. Bayliss, D. Osborne, S. Woodhouse, and C. Davidson Sulfation of chondroitin sulfate in human articular cartilage. The effect of age, topographical position, and zone of cartilage on tissue composition J. Biol. Chem. 274 1999 15892 15900
8. A.J. Deutsch, R.J. Midura, and A.H. Plaas Structure of chondroitin sulfate on aggrecan isolated from bovine tibial and costochondral growth plates J. Orthop. Res. 13 1995 230 239
9. H. Watanabe, S.C. Cheung, N. Itano, K. Kimata, and Y. Yamada Identification of hyaluronan-binding domains of aggrecan J. Biol. Chem. 272 1997 28057 28065
10. P.J. Neame, and F.P. Barry The link proteins Experientia 49 1993 393 402
11. F.P. Barry, L.C. Rosenberg, J.U. Gaw, J.U. Gaw, T.J. Koob, and P.J. Neame N- and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage J. Biol. Chem. 270 1995 20516 20524
12. A.J. Fosang, P.J. Neame, K. Last, T.E. Hardingham, G. Murphy, and J.A. Hamilton The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B J. Biol. Chem. 267 1992 19470 19474
13. A.J. Fosang, and T.E. Hardingham Isolation of the N-terminal globular protein domains from cartilage proteoglycans. Identification of G2 domain and its lack of interaction with hyaluronate and link protein Biochem. J. 261 1989 801 809
14. V. Santer, R.J. White, and P.J. Roughley O-Linked oligosaccharides of human articular cartilage proteoglycan Biochim. Biophys. Acta 716 1982 277 282
15. F.P. Barry, P.J. Neame, J. Sasse, and D. Pearson Length variation in the keratan sulfate domain of mammalian aggrecan Matrix Biol. 14 1994 323 328
16. E. Rodriguez, S.K. Roland, A. Plaas, and P.J. Roughley The glycosaminoglycan attachment regions of human aggrecan J. Biol. Chem. 281 2006 18444 18450
17. K.J. Doege, S.N. Coulter, L.M. Meek, K. Maslen, and J.G. Wood A human-specific polymorphism in the coding region of the aggrecan gene. Variable number of tandem repeats produce a range of core protein sizes in the general population J. Biol. Chem. 272 1997 13974 13979
18. Y. Kawaguchi, R. Osada, M. Kanamori, H. Ishihara, K. Ohmori, H. Matsui, and T. Kimura Association between an aggrecan gene polymorphism and lumbar disc degeneration Spine (Phila Pa 1976) 24 1999 2456 2460
19. P.J. Roughley, and R.J. White Age-related changes in the structure of the proteoglycan subunits from human articular cartilage J. Biol. Chem. 255 1980 217 224
20. J. Zheng, W. Luo, and M.L. Tanzer Aggrecan synthesis and secretion. A paradigm for molecular and cellular coordination of multiglobular protein folding and intracellular trafficking J. Biol. Chem. 273 1998 12999 13006
21. C. Fulop, E. Walcz, M. Valyon, and T.T. Glant Expression of alternatively spliced epidermal growth factor-like domains in aggrecans of different species. Evidence for a novel module J. Biol. Chem. 268 1993 17377 17383
22. A.I. Olin, M. Morgelin, T. Sasaki, R. Timpl, D. Heinegard, and A. Aspberg The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding J. Biol. Chem. 276 2001 1253 1261
23. J. Dudhia, C.M. Davidson, T.M. Wells, T.E. Hardingham, and M.T. Bayliss Studies on the G3 domain of aggrecan from human cartilage Ann. N. Y. Acad. Sci. 785 1996 245 247
24. L.I. Melching, and P.J. Roughley Studies on the interaction of newly secreted proteoglycan subunits with hyaluronate in human articular cartilage Biochim. Biophys. Acta 1035 1990 20 28
25. V.C. Hascall Proteoglycans: the chondroitin sulfate/keratan sulfate proteoglycan of cartilage ISI Atlas Sci. Biochem. 1 1988 198
26. L. Gleghorn, R. Ramesar, P. Beighton, and G. Wallis A mutation in the variable repeat region of the aggrecan gene (AGC1) causes a form of spondyloepiphyseal dysplasia associated with severe, premature osteoarthritis Am. J. Hum. Genet. 77 2005 484 490
27. O. Nilsson, M.H. Guo, N. Dunbar, J. Popovic, D. Flynn, C. Jacobsen, J.C. Lui, J.N. Hirschhorn, J. Baron, and A. Dauber Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations J. Clin. Endocrinol. Metab. 2014 (jc20141332)
28. E.L. Stattin, F. Wiklund, K. Lindblom, P. Onnerfjord, B.A. Jonsson, Y. Tegner, T. Sasaki, A. Struglics, S. Lohmander, N. Dahl, D. Heinegard, and A. Aspberg A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans Am. J. Hum. Genet. 86 2010 126 137
29. S.W. Tompson, B. Merriman, V.A. Funari, M. Fresquet, R.S. Lachman, D.L. Rimoin, S.F. Nelson, M.D. Briggs, D.H. Cohn, and D. Krakow A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan Am. J. Hum. Genet. 84 2009 72 79
30. A. Rossi, J. Bonaventure, A.L. Delezoide, G. Cetta, and A. Superti-Furga Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter J. Biol. Chem. 271 1996 18456 18464
31. P.J. Roughley, L.I. Melching, T.F. Heathfield, R.H. Pearce, and J.S. Mort The structure and degradation of aggrecan in human intervertebral disc Eur. Spine J. 15 Suppl. 3 2006 S326 S332
32. W.E. Johnson, B. Caterson, S.M. Eisenstein, and S. Roberts Human intervertebral disc aggrecan inhibits endothelial cell adhesion and cell migration in vitro Spine (Phila Pa 1976) 30 2005 1139 1147
33. W.E. Johnson, B. Caterson, S.M. Eisenstein, D.L. Hynds, D.M. Snow, and S. Roberts Human intervertebral disc aggrecan inhibits nerve growth in vitro Arthritis Rheum. 46 2002 2658 2664
34. G.I. Hristova, P. Jarzem, J.A. Ouellet, P.J. Roughley, L.M. Epure, J. Antoniou, and F. Mwale Calcification in human intervertebral disc degeneration and scoliosis J. Orthop. Res. 29 2011 1888 1895
35. R. Sztrolovics, M. Alini, P.J. Roughley, and J.S. Mort Aggrecan degradation in human intervertebral disc and articular cartilage Biochem. J. 326 Pt 1 1997 235 241
36. J.C. Iatridis, K. Godburn, K. Wuertz, M. Alini, and P.J. Roughley Region-dependent aggrecan degradation patterns in the rat Intervertebral disc are affected by mechanical loading in vivo Spine 2010 203 209
37. J. Wang, D. Markova, D.G. Anderson, Z. Zheng, I.M. Shapiro, and M.V. Risbud TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc J. Biol. Chem. 286 2011 39738 39749
38. M. Durigova, H. Nagase, J.S. Mort, and P.J. Roughley MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein Matrix Biol. 30 2011 145 153
39. M.D. Tortorella, R.Q. Liu, T. Burn, R.C. Newton, and E. Arner Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4) Matrix Biol. 21 2002 499 511
40. C. Gendron, M. Kashiwagi, N.H. Lim, J.J. Enghild, I.B. Thogersen, C. Hughes, B. Caterson, and H. Nagase Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4 J. Biol. Chem. 282 2007 18294 18306
41. G. Lepperdinger, J. Mullegger, and G. Kreil Hyal2 - less active, but more versatile? Matrix Biol. 20 2001 509 514
42. R. Stern, G. Kogan, M.J. Jedrzejas, and L. Soltes The many ways to cleave hyaluronan Biotechnol. Adv. 25 2007 537 557
43. E. Rodriguez, and P. Roughley Link protein can retard the degradation of hyaluronan in proteoglycan aggregates Osteoarthritis Cartilage 14 2006 823 829
44. S.S. Sivan, E. Tsitron, E. Wachtel, P. Roughley, N. Sakkee, F. van der Ham, J. Degroot, and A. Maroudas Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs Biochem. J. 399 2006 29 35
45. J.L. Bada In vivo racemization in mammalian proteins Methods Enzymol. 106 1984 98 115
46. P.M. Helfman, and J.L. Bada Aspartic acid racemization in tooth enamel from living humans Proc. Natl. Acad. Sci. U. S. A. 72 1975 2891 2894
47. P.M. Helfman, and J.L. Bada Aspartic acid racemisation in dentine as a measure of ageing Nature 262 1976 279 281
48. E.H. Man, M.E. Sandhouse, J. Burg, and G.H. Fisher Accumulation of D-aspartic acid with age in the human brain Science 220 1983 1407 1408
49. P.M. Masters, J.L. Bada, and J.S. Zigler Jr. Aspartic acid racemisation in the human lens during ageing and in cataract formation Nature 268 1977 71 73
50. J.T. Powell, N. Vine, and M. Crossman On the accumulation of D-aspartate in elastin and other proteins of the ageing aorta Atherosclerosis 97 1992 201 208
51. N. Verzijl, J. DeGroot, R.A. Bank, M.T. Bayliss, J.W. Bijlsma, F.P. Lafeber, A. Maroudas, and J.M. TeKoppele Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover Matrix Biol. 20 2001 409 417
52. N. Verzijl, J. DeGroot, S.R. Thorpe, R.A. Bank, J.N. Shaw, T.J. Lyons, J.W. Bijlsma, F.P. Lafeber, J.W. Baynes, and J.M. TeKoppele Effect of collagen turnover on the accumulation of advanced glycation end products J. Biol. Chem. 275 2000 39027 39031
53. S. Ritz-Timme, I. Laumeier, and M.J. Collins Aspartic acid racemization: evidence for marked longevity of elastin in human skin Br. J. Dermatol. 149 2003 951 959
54. J.L. Bada, K.A. Kvenvolden, and E.T. Peterson Racemization of amino acids in bones Nature 245 1973 308 310
55. S. Ohtani, Y. Matsushima, Y. Kobayashi, and K. Kishi Evaluation of aspartic acid racemization ratios in the human femur for age estimation J. Forensic Sci. 43 1998 949 953
56. C.T. Thorpe, I. Streeter, G.L. Pinchbeck, A.E. Goodship, P.D. Clegg, and H.L. Birch Aspartic acid racemization and collagen degradation markers reveal an accumulation of damage in tendon collagen that is enhanced with aging J. Biol. Chem. 285 2010 15674 15681
57. R.C. Dobberstein, S.M. Tung, and S. Ritz-Timme Aspartic acid racemisation in purified elastin from arteries as basis for age estimation Int. J. Legal Med. 124 2009 269 275
58. S. Ritz, and H.W. Schutz Aspartic acid racemization in intervertebral discs as an aid to postmortem estimation of age at death J. Forensic Sci. 38 1993 633 640
59. S.S. Sivan, E. Tsitron, E. Wachtel, P.J. Roughley, N. Sakkee, F. van der Ham, J. DeGroot, S. Roberts, and A. Maroudas Aggrecan turnover in human intervertebral disc as determined by the racemization of aspartic acid J. Biol. Chem. 281 2006 13009 13014
60. S.S. Sivan, B. Van El, Y. Merkher, C.E. Schmelzer, A.M. Zuurmond, A. Heinz, E. Wachtel, P.P. Varga, A. Lazary, M. Brayda-Bruno, and A. Maroudas Longevity of elastin in human intervertebral disc as probed by the racemization of aspartic acid Biochim. Biophys. Acta 1820 2012 1671 1677
61. S.S. Sivan, E. Wachtel, E. Tsitron, N. Sakkee, F. van der Ham, J. Degroot, S. Roberts, and A. Maroudas Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid J. Biol. Chem. 283 2008 8796 8801
62. I.M. London, R. West, D. Shemin, and D. Rittenberg On the origin of bile pigment in normal man J. Biol. Chem. 184 1950 351 358
63. V.C. Duance, J.K. Crean, T.J. Sims, N. Avery, S. Smith, J. Menage, S.M. Eisenstein, and S. Roberts Changes in collagen cross-linking in degenerative disc disease and scoliosis Spine 23 1998 2545 2551
64. A.J. Bailey, S.F. Wotton, T.J. Sims, and P.W. Thompson Biochemical changes in the collagen of human osteoporotic bone matrix Connect. Tissue Res. 29 1993 119 132
65. R.A. Bank, M.T. Bayliss, F.P. Lafeber, A. Maroudas, and J.M. Tekoppele Ageing and zonal variation in post-translational modification of collagen in normal human articular cartilage. The age-related increase in non-enzymatic glycation affects biomechanical properties of cartilage Biochem. J. 330 Pt 1 1998 345 351
66. A.C. Chen, M.M. Temple, D.M. Ng, N. Verzijl, J. DeGroot, J.M. TeKoppele, and R.L. Sah Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage Arthritis Rheum. 46 2002 3212 3217
67. S.I. Rattan, A. Derventzi, and B.F. Clark Protein synthesis, posttranslational modifications, and aging Ann. N. Y. Acad. Sci. 663 1992 48 62
68. E.R. Stadtman, and R.L. Levine Protein oxidation Ann. N. Y. Acad. Sci. 899 2000 191 208
69. N. Verzijl, J. DeGroot, Z.C. Ben, O. Brau-Benjamin, A. Maroudas, R.A. Bank, J. Mizrahi, C.G. Schalkwijk, S.R. Thorpe, J.W. Baynes, J.W. Bijlsma, F.P. Lafeber, and J.M. TeKoppele Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis Arthritis Rheum. 46 2002 114 123
70. T.L. Willett, R. Kandel, J.N. De Croos, N.C. Avery, and M.D. Grynpas Enhanced level of non-enzymatic glycation and pentosidine crosslinking in spontaneous osteoarthritis progression Osteoarthritis Cartilage 20 2012 736 744
71. J.L. Bada In vivo racemization in mammalian proteins K. Moldav, F. Wold, Posttranslational modifications, in: Methods Enzymol 106 1984 Academic Press New-York 98 115
72. M.T. Bayliss Proteoglycan structure and metabolism during maturation and ageing of human articular cartilage Biochem. Soc. Trans. 18 1990 799 802
73. V. Vilim, and A.J. Fosang Proteoglycans isolated from dissociative extracts of differently aged human articular cartilage: characterization of naturally occurring hyaluronan-binding fragments of aggrecan Biochem. J. 304 Pt. 3 1994 887 894
74. M.C. Bolton, J. Dudhia, and M.T. Bayliss Age-related changes in the synthesis of link protein and aggrecan in human articular cartilage: implications for aggregate stability Biochem. J. 337 Pt. 1 1999 77 82
75. J.H. McKerrow Non-enzymatic, post-translational, amino acid modifications in ageing. A brief review Mech. Ageing Dev. 10 1979 371 377
76. N.E. Robinson, and A.B. Robinson Prediction of protein deamidation rates from primary and three-dimensional structure Proc. Natl. Acad. Sci. U. S. A. 98 2001 4367 4372
77. R.F. Rosenberger Senescence and the accumulation of abnormal proteins Mutat. Res. 256 1991 255 262
78. J. Sajdok, A. Kotrbova-Kozak, and A. Pilin Age determination using peptide mapping of non-collagenous proteins in human dentin Soud. Lek. 46 2001 5 8
79. T. Geiger, and S. Clarke Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation J. Biol. Chem. 262 1987 785 794
80. J.L. Bada Racemization of amino acids in nature Interdisc. Sci. Rev. 7 1982 30 46
81. P.M. Helfman, J.L. Bada, and M.Y. Shou Considerations on the role of aspartic acid racemization in the aging process Gerontology 23 1977 419 425
82. N.E. Robinson, and A.B. Robinson Molecular Clocks Proc. Natl. Acad. Sci. USA 98 2001 944 949
83. J. Lowenson, and S. Clarke Does the chemical instability of aspartyl and asparaginyl residues in proteins contribute to erythrocyte aging? The role of protein carboxyl methylation reactions Blood Cells 14 1988 103 118
84. P.M. Masters, J.L. Bada, and J.S. Zigler Jr. Aspartic acid racemization in heavy molecular weight crystallins and water insoluble protein from normal human lenses and cataracts Proc. Natl. Acad. Sci. 75 1978 1204 1208
85. A.E. Roher, J.D. Lowenson, S. Clarke, C. Wolkow, R. Wang, R.J. Cotter, I.M. Reardon, H.A. Zurcher-Neely, R.L. Heinrikson, and M.J. Ball Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease J. Biol. Chem. 268 1993 3072 3083
86. T. Shimizu, A. Watanabe, M. Ogawara, H. Mori, and T. Shirasawa Isoaspartate formation and neurodegeneration in Alzheimer's disease Arch. Biochem. Biophys. 381 2000 225 234
87. T. Tomiyama, S. Asano, Y. Furiya, T. Shirasawa, N. Endo, and H. Mori Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues J. Biol. Chem. 269 1994 10205 10208
88. M.A. Adams, and P.J. Roughley What is intervertebral disc degeneration, and what causes it? Spine (Phila Pa 1976) 31 2006 2151 2161
89. C.K. Kepler, R.K. Ponnappan, C.A. Tannoury, M.V. Risbud, and D.G. Anderson The molecular basis of intervertebral disc degeneration Spine J. 13 2013 318 330
90. J.E. Mayer, J.C. Iatridis, D. Chan, S.A. Qureshi, O. Gottesman, and A.C. Hecht Genetic polymorphisms associated with intervertebral disc degeneration Spine J. 13 2013 299 317
91. J. Garcia-Cosamalon, M.E. del Valle, M.G. Calavia, O. Garcia-Suarez, A. Lopez-Muniz, J. Otero, and J.A. Vega Intervertebral disc, sensory nerves and neurotrophins: who is who in discogenic pain? J. Anat. 217 2010 1 15
92. P.P. Raj Intervertebral disc: anatomy-physiology-pathophysiology- treatment Pain Pract. 8 2008 18 44
93. K. Masuda Biological repair of the degenerated intervertebral disc by the injection of growth factors Eur. Spine J. 17 Suppl. 4 2008 441 451
94. F. Mwale, C.N. Demers, A. Petit, P. Roughley, A.R. Poole, T. Steffen, M. Aebi, and J. Antoniou A synthetic peptide of link protein stimulates the biosynthesis of collagens II, IX and proteoglycan by cells of the intervertebral disc J. Cell. Biochem. 88 2003 1202 1213
95. R. Gawri, J. Antoniou, J. Ouellet, W. Awwad, T. Steffen, P. Roughley, L. Haglund, and F. Mwale Link-N can stimulate proteoglycan synthesis in the degenerated human intervertebral discs Eur. Cell Mater. 26 2013 107 119
96. Z. Wang, M.N. Weitzmann, S. Sangadala, W.C. Hutton, and S.T. Yoon Link protein N-terminal peptide binds to bone morphogenetic protein (BMP) type II receptor and drives matrix protein expression in rabbit intervertebral disc cells J. Biol. Chem. 288 2013 28243 28253
97. J. Antoniou, H.T. Wang, A.M. Alaseem, L. Haglund, P.J. Roughley, and F. Mwale The effect of Link N on differentiation of human bone marrow-derived mesenchymal stem cells Arthritis Res. Ther. 14 2012 R267
98. F. Mwale, K. Masuda, R. Pichika, L.M. Epure, T. Yoshikawa, A. Hemmad, P.J. Roughley, and J. Antoniou The efficacy of Link N as a mediator of repair in a rabbit model of intervertebral disc degeneration Arthritis Res. Ther. 13 2011 R120
99. A.J. Michalek, M.R. Buckley, L.J. Bonassar, I. Cohen, and J.C. Iatridis The effects of needle puncture injury on microscale shear strain in the intervertebral disc annulus fibrosus Spine J. 10 2010 1098 1105
100. S.S. Sivan, S. Roberts, J.P. Urban, J. Menage, J. Bramhill, D. Campbell, V.J. Franklin, F. Lydon, Y. Merkher, A. Maroudas, and B.J. Tighe Injectable hydrogels with high fixed charge density and swelling pressure for nucleus pulposus repair: biomimetic glycosaminoglycan analogues Acta Biomater. 10 2014 1124 1133
101. J.C. Bernhard, and A. Panitch Synthesis and characterization of an aggrecan mimic Acta Biomater. 8 2012 1543 1550
102. S. Sharma, A. Lee, K. Choi, K. Kim, I. Youn, S.B. Trippel, and A. Panitch Biomimetic aggrecan reduces cartilage extracellular matrix from degradation and lowers catabolic activity in ex vivo and in vivo models Macromol. Biosci. 13 2013 1228 1237
103. S. Sharma, A. Panitch, and C.P. Neu Incorporation of an aggrecan mimic prevents proteolytic degradation of anisotropic cartilage analogs Acta Biomater. 9 2013 4618 4625